Kura Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015
Market Capitalization	1,288	1,068	830	932	1,852	623	534	462	126	180
Market Cap Growth	-	28.65%	-10.90%	-49.69%	197.25%	16.67%	15.52%	266.70%	-29.77%	-
Enterprise Value	939	661	406	420	1,231	394	363	376	66	94
PE Ratio	-7.00	-7.00	-6.11	-7.14	-20.66	-9.87	-8.84	-13.05	-4.57	-7.93
PB Ratio	3.39	2.69	1.98	1.84	3.03	2.85	3.32	5.79	2.22	2.19
P/FCF Ratio	-8.54	-8.54	-7.50	-8.82	-25.72	-11.38	-10.98	-16.25	-4.97	-9.98
P/OCF Ratio	-8.56	-8.56	-7.54	-8.91	-26.52	-11.38	-10.98	-16.25	-4.97	-10.01
EV/EBITDA Ratio	-4.40	-4.40	-3.01	-3.25	-13.86	-6.29	-6.10	-10.90	-2.43	-4.16
EV/EBIT Ratio	-4.38	-4.38	-3.00	-3.23	-13.83	-6.29	-6.10	-10.89	-2.43	-4.16
EV/FCF Ratio	-5.29	-5.29	-3.67	-3.98	-17.10	-7.19	-7.45	-13.23	-2.59	-5.21
Debt / Equity Ratio	0.04	0.04	0.03	0.01	0.02	0.03	0.05	0.09	0.13	-
Debt / EBITDA Ratio	-0.11	-0.11	-0.10	-0.05	-0.15	-0.12	-0.13	-0.21	-0.27	-
Debt / FCF Ratio	-0.14	-0.14	-0.13	-0.07	-0.18	-0.14	-0.15	-0.25	-0.29	-
Quick Ratio	12.02	12.02	18.21	23.08	24.34	15.22	13.16	9.31	12.49	17.05
Current Ratio	12.26	12.26	18.56	23.26	24.49	15.40	13.31	9.44	12.62	17.18
Interest Coverage	-97.54	-97.54	-592.19	-314.14	-154.06	-107.86	-61.32	-38.90	-46.76	-256.10
Return on Equity (ROE)	-36.30%	-36.30%	-30.80%	-23.90%	-24.80%	-29.80%	-42.20%	-53.90%	-41.30%	-42.70%
Return on Assets (ROA)	-33.10%	-33.10%	-29.00%	-22.70%	-22.90%	-27.10%	-37.50%	-44.70%	-35.80%	-38.90%
Return on Capital (ROIC)	-40.00%	-40.00%	-32.20%	-25.56%	-14.73%	-29.82%	-37.32%	-41.49%	-38.22%	-24.35%
Earnings Yield	-11.34%	-14.29%	-16.36%	-14.00%	-4.84%	-10.13%	-11.32%	-7.66%	-21.86%	-12.60%
FCF Yield	-9.29%	-11.70%	-13.33%	-11.34%	-3.89%	-8.79%	-9.11%	-6.15%	-20.11%	-10.02%
Buyback Yield / Dilution	-9.31%	-9.31%	-0.96%	-25.01%	-26.54%	-19.20%	-51.44%	-24.26%	-88.27%	-
Total Shareholder Return	-9.31%	-9.31%	-0.96%	-25.01%	-26.54%	-19.20%	-51.44%	-24.26%	-88.27%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).